34.56 USD
+1.56 (+4.73%)
Overall PDEX gets a fundamental rating of 5 out of 10. We evaluated PDEX against 188 industry peers in the Health Care Equipment & Supplies industry. PDEX has an excellent profitability rating, but there are some minor concerns on its financial health. PDEX is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
PDEX had positive earnings in the past year.
PDEX had a negative operating cash flow in the past year.
PDEX had positive earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: PDEX reported negative operating cash flow in multiple years.
1.2 Ratios
Looking at the Return On Assets, with a value of 17.41%, PDEX belongs to the top of the industry, outperforming 97.87% of the companies in the same industry.
PDEX has a better Return On Equity (26.96%) than 97.34% of its industry peers.
The Return On Invested Capital of PDEX (16.51%) is better than 96.28% of its industry peers.
The Average Return On Invested Capital over the past 3 years for PDEX is significantly above the industry average of 8.71%.
The last Return On Invested Capital (16.51%) for PDEX is above the 3 year average (14.16%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.41% | ||
| ROE | 26.96% | ||
| ROIC | 16.51% |
ROA(3y)10.79%
ROA(5y)11.4%
ROE(3y)17.93%
ROE(5y)20.5%
ROIC(3y)14.16%
ROIC(5y)12.68%
1.3 Margins
PDEX has a Profit Margin of 15.94%. This is amongst the best in the industry. PDEX outperforms 91.49% of its industry peers.
In the last couple of years the Profit Margin of PDEX has declined.
The Operating Margin of PDEX (15.36%) is better than 84.57% of its industry peers.
PDEX's Operating Margin has declined in the last couple of years.
PDEX's Gross Margin of 28.09% is on the low side compared to the rest of the industry. PDEX is outperformed by 77.13% of its industry peers.
In the last couple of years the Gross Margin of PDEX has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.36% | ||
| PM (TTM) | 15.94% | ||
| GM | 28.09% |
OM growth 3Y9.36%
OM growth 5Y-4.56%
PM growth 3Y7.44%
PM growth 5Y-5.13%
GM growth 3Y-2.11%
GM growth 5Y-4.93%
2. Health
2.1 Basic Checks
PDEX has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
PDEX has less shares outstanding than it did 1 year ago.
The number of shares outstanding for PDEX has been reduced compared to 5 years ago.
Compared to 1 year ago, PDEX has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 6.07 indicates that PDEX is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 6.07, PDEX belongs to the best of the industry, outperforming 80.32% of the companies in the same industry.
A Debt/Equity ratio of 0.21 indicates that PDEX is not too dependend on debt financing.
The Debt to Equity ratio of PDEX (0.21) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 6.07 |
ROIC/WACC2
WACC8.25%
2.3 Liquidity
A Current Ratio of 3.73 indicates that PDEX has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 3.73, PDEX is in the better half of the industry, outperforming 66.49% of the companies in the same industry.
A Quick Ratio of 2.14 indicates that PDEX has no problem at all paying its short term obligations.
With a Quick ratio value of 2.14, PDEX perfoms like the industry average, outperforming 54.79% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.73 | ||
| Quick Ratio | 2.14 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 107.14% over the past year.
PDEX shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.96% yearly.
Looking at the last year, PDEX shows a very strong growth in Revenue. The Revenue has grown by 23.65%.
The Revenue has been growing by 13.84% on average over the past years. This is quite good.
EPS 1Y (TTM)107.14%
EPS 3Y35.1%
EPS 5Y10.96%
EPS Q2Q%86.67%
Revenue 1Y (TTM)23.65%
Revenue growth 3Y16.57%
Revenue growth 5Y13.84%
Sales Q2Q%24.43%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-4.43%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.48%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 10.83, the valuation of PDEX can be described as reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of PDEX indicates a rather cheap valuation: PDEX is cheaper than 93.09% of the companies listed in the same industry.
PDEX's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.65.
A Price/Forward Earnings ratio of 14.24 indicates a correct valuation of PDEX.
87.77% of the companies in the same industry are more expensive than PDEX, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 34.45. PDEX is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.83 | ||
| Fwd PE | 14.24 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, PDEX is valued cheaply inside the industry as 94.15% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 8.38 |
4.3 Compensation for Growth
PDEX has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.99
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for PDEX!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:PDEX (11/25/2025, 11:06:00 AM)
34.56
+1.56 (+4.73%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners32.91%
Inst Owner Change-3.05%
Ins Owners35.95%
Ins Owner Change1.39%
Market Cap113.36M
Revenue(TTM)70.23M
Net Income(TTM)11.19M
Analysts82.86
Price Target57.12 (65.28%)
Short Float %11.07%
Short Ratio4.11
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)74.8%
Min EPS beat(2)-24.91%
Max EPS beat(2)174.51%
EPS beat(4)3
Avg EPS beat(4)69.51%
Min EPS beat(4)-24.91%
Max EPS beat(4)174.51%
EPS beat(8)5
Avg EPS beat(8)44.11%
EPS beat(12)7
Avg EPS beat(12)20.2%
EPS beat(16)8
Avg EPS beat(16)16.17%
Revenue beat(2)1
Avg Revenue beat(2)7.28%
Min Revenue beat(2)-4.18%
Max Revenue beat(2)18.74%
Revenue beat(4)2
Avg Revenue beat(4)7.58%
Min Revenue beat(4)-4.18%
Max Revenue beat(4)19.3%
Revenue beat(8)6
Avg Revenue beat(8)12.93%
Revenue beat(12)9
Avg Revenue beat(12)11.32%
Revenue beat(16)12
Avg Revenue beat(16)11.48%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.83 | ||
| Fwd PE | 14.24 | ||
| P/S | 1.61 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 2.73 | ||
| P/tB | 2.73 | ||
| EV/EBITDA | 8.38 |
EPS(TTM)3.19
EY9.23%
EPS(NY)2.43
Fwd EY7.02%
FCF(TTM)-0.66
FCFYN/A
OCF(TTM)-0.38
OCFYN/A
SpS21.41
BVpS12.66
TBVpS12.65
PEG (NY)N/A
PEG (5Y)0.99
Graham Number30.14
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.41% | ||
| ROE | 26.96% | ||
| ROCE | 21.27% | ||
| ROIC | 16.51% | ||
| ROICexc | 20.85% | ||
| ROICexgc | 20.86% | ||
| OM | 15.36% | ||
| PM (TTM) | 15.94% | ||
| GM | 28.09% | ||
| FCFM | N/A |
ROA(3y)10.79%
ROA(5y)11.4%
ROE(3y)17.93%
ROE(5y)20.5%
ROIC(3y)14.16%
ROIC(5y)12.68%
ROICexc(3y)16.6%
ROICexc(5y)14.6%
ROICexgc(3y)16.62%
ROICexgc(5y)14.63%
ROCE(3y)18.25%
ROCE(5y)16.34%
ROICexgc growth 3Y23.73%
ROICexgc growth 5Y-8.41%
ROICexc growth 3Y23.84%
ROICexc growth 5Y-8.25%
OM growth 3Y9.36%
OM growth 5Y-4.56%
PM growth 3Y7.44%
PM growth 5Y-5.13%
GM growth 3Y-2.11%
GM growth 5Y-4.93%
F-Score6
Asset Turnover1.09
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 0.72 | ||
| Cap/Depr | 73.12% | ||
| Cap/Sales | 1.3% | ||
| Interest Coverage | 12.57 | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.73 | ||
| Quick Ratio | 2.14 | ||
| Altman-Z | 6.07 |
F-Score6
WACC8.25%
ROIC/WACC2
Cap/Depr(3y)99.37%
Cap/Depr(5y)344.26%
Cap/Sales(3y)1.93%
Cap/Sales(5y)6.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)107.14%
EPS 3Y35.1%
EPS 5Y10.96%
EPS Q2Q%86.67%
EPS Next Y-4.43%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)23.65%
Revenue growth 3Y16.57%
Revenue growth 5Y13.84%
Sales Q2Q%24.43%
Revenue Next Year4.48%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y29.16%
EBIT growth 3Y27.48%
EBIT growth 5Y8.65%
EBIT Next Year10.43%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-206.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-142.63%
OCF growth 3YN/A
OCF growth 5YN/A
PRO-DEX INC / PDEX FAQ
Can you provide the ChartMill fundamental rating for PRO-DEX INC?
ChartMill assigns a fundamental rating of 5 / 10 to PDEX.
Can you provide the valuation status for PRO-DEX INC?
ChartMill assigns a valuation rating of 5 / 10 to PRO-DEX INC (PDEX). This can be considered as Fairly Valued.
Can you provide the profitability details for PRO-DEX INC?
PRO-DEX INC (PDEX) has a profitability rating of 7 / 10.
Can you provide the expected EPS growth for PDEX stock?
The Earnings per Share (EPS) of PRO-DEX INC (PDEX) is expected to decline by -4.43% in the next year.